GLI1 and liver cancer: For further exploration of the involvement of the SHH/Gli axis in liver cancer stem cell activity, CD90+ 97L and Huh7 liver cancer cells were treated with 0.4 g/mL SHH (SRP3156; Sigma‐Aldrich).